Kellie Sprague MD (She/Her)

Hematologic Oncology

Director, Hematologic Malignancies Program

MaineHealth Cancer Care/Maine Medical CenterSuite 2Portland, ME 04106
Phone+1 207-661-0200

Dr. Sprague is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sprague's full profile Already have an account?

Summary

Dr. Kellie Sprague is a hematologist in Portland, ME and is affiliated with Maine Medical Center. She received her medical degree from University of Vermont College of Medicine and has been in practice 26 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myeloproliferative disorders, myelodysplasia, and myelofibrosis.

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
Tufts Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Vermont College of MedicineClass of 1991

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

ME State Medical License 2020 - 2026
NH State Medical License 2024 - 2024
MA State Medical License 1997 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Boston Magazine Castle Connolly, 2010-2020
CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2015

Clinical Trials

Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
COMPLETED
PHASE3
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
COMPLETED
PHASE2
Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens
TERMINATED
PHASE2

Publications & Presentations

PubMed

3 citations
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402...
Francine M. Foss, Xin Victoria Wang, Selina M. Luger, Opeyemi Jegede, Kenneth B. Miller
Transfusion. 2020-07-12
13 citations
Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematolo...
Chakra P Chaulagain, Kellie Sprague, Monika Pilichowska, Janet M. Cowan, Andreas K. Klein
Bone Marrow Transplantation. 2019-04-01
24 citations
Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth
Xun Ma, Sandy W. Wong, Ping Zhou, Chakra P Chaulagain, Parul Doshi
Experimental Hematology & Oncology. 2018-10-16

Journal Articles

Clinicopathologic Characteristics of Secondary Squamous Cell Carcinoma of Head and Neck in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation for Hematolo...
Kenneth B Miller, Kellie A Sprague, Chakra P Chaulagain, Esha Kaul, Andreas K Klein, Janet Cowan, Nature
A randomized, double-blinded, placebo-controlled trial of valacyclovir prophylaxis to prevent herpes zoster recurrence from months 4 to 24 months after BMT
Klein A, Miller KB, Sprague K, Desjardin JA, Snydman DR, Bone Marrow Transplantation
Prospective Study of Extracoporeal Photopheresis in Steroid-refractory or Steroid-resistant Extensive Chronic Graft-versus-Host-Disease: Analysis of Response & Surviva...
Foss FM, DiVenuti GM, Chin K, Sprague K, Grodman H, Klein A, Chan G, Stiffer K. Miller KB, Bone Marrow Transplantation

Books/Book Chapters